Thermo Fisher Scientific
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Thermo Fisher Scientific generated cash of $8,406,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$3,622,000,000 last year. Net change in cash is therefore -$440,000,000.
Cash Flow
| 2014 | 2.61B | -11.78B | 4.79B |
|---|---|---|---|
| 2015 | 2.81B | -1.08B | -2.49B |
| 2016 | 3.15B | -5.53B | 2.86B |
| 2017 | 4.00B | -7.72B | 3.85B |
| 2018 | 4.54B | -1.25B | -2.23B |
| 2019 | 4.97B | -1.48B | -3.11B |
| 2020 | 8.28B | -1.51B | 959M |
| 2021 | 9.54B | -21.93B | 6.58B |
| 2022 | 9.15B | -2.15B | -2.81B |
| 2023 | 8.40B | -5.14B | -3.62B |
0R0H.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 8.53B | 4.49B | 10.33B | 2.42B | 2.11B | 1.36B | 811M | 452.1M | 1.34B | 5.82B |
Operating activities | ||||||||||
Net income | 5.99B | 6.96B | 7.72B | 6.37B | 3.69B | 2.93B | 2.22B | 2.02B | 1.98B | 1.89B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.40B | 3.38B | 2.59B | 2.32B | 2.27B | 2.26B | 2.03B | 1.75B | 1.68B | 1.68B |
Stock-based compensation expense | 278M | 307M | 230M | 196M | 181M | 181M | 159M | 133.5M | 125M | 117.1M |
| Deferred income tax benefit | 278M | 307M | 230M | 196M | 181M | 181M | 159M | 133.5M | 125M | 117.1M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 209M | -430M | -204M | -1.30B | -225M | -366M | -362M | -352.2M | -149.4M | -145.4M |
Inventories | 598M | -825M | -1.06B | -508M | -458M | -324M | -81M | 97.8M | -140.7M | -109.8M |
Accounts payable | -500M | 648M | 479M | 59M | 266M | 201M | 274M | 55.5M | -2.7M | 1.2M |
Cash generated by operating activities | 8.40B | 9.15B | 9.54B | 8.28B | 4.97B | 4.54B | 4.00B | 3.15B | 2.81B | 2.61B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -15M | -8M | 0 | 0 | 0 | -15M | -54.9M | 6.1M | -39.3M |
Investments In Property Plant And Equipment | -1.47B | -2.24B | -2.52B | -1.47B | -926M | -758M | -508M | -444.4M | -422.9M | -427.6M |
Acquisitions Net | -3.66B | -39M | -19.39B | -38M | -715M | -536M | -7.22B | -5.18B | -694.6M | -11.53B |
Cash generated by investing activities | -5.14B | -2.15B | -21.93B | -1.51B | -1.48B | -1.25B | -7.72B | -5.53B | -1.08B | -11.78B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 20.80B | 4.04B | 153M | 136M | 1.69B | 135.3M | 0 | 0 |
Payments for dividends | -523M | -455M | -395M | -337M | -297M | -266M | -237M | -238.4M | -240.6M | -234.8M |
Repurchases of common stock | -3B | -3B | -2B | -1.5B | -1.5B | -500M | -750M | -1.25B | -500M | 0 |
Repayments of term debt | -155M | 654M | -11.73B | -1.1B | -717M | -7.30B | 3.02B | -4.33B | -1.94B | 2.12B |
Cash used in financing activities | -3.62B | -2.81B | 6.58B | 959M | -3.11B | -2.23B | 3.85B | 2.86B | -2.49B | 4.79B |
Net Change In Cash | -440M | 4.04B | -5.84B | 7.91B | 305M | 756M | 550M | 334.1M | -891.4M | -4.48B |
Cash at end of period | 8.09B | 8.53B | 4.49B | 10.33B | 2.42B | 2.11B | 1.36B | 786.2M | 452.1M | 1.34B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |